You are here: Industry Insights > CAPA

News List

HIV and the Antiretroviral Therapy Capsid Inhibitor Lenacapavir David Orchard-Webb
January 07, 2025
HIV is a major worldwide health issue, producing substantial morbidity and mortality.HIV targets the immune system, primarily CD4+ T cells, depleting them and making the body susceptible to opportunistic infections and malignancies.
A Glimpse of the Capacity and Supply of Blood Products Made in China Xiaoyaowan
February 08, 2023
Gamma globulin is the passive immunity preparation, of which the most widely used product in the clinical practice is the human immunoglobulin for intravenous injection, referred to PH4.
Africa Expands Vaccine Manufacturing Capacity Shem Oirere
March 08, 2022
The outbreak of COVID-19 pandemic has revived the drive by governments in Africa to expand local pharmaceutical manufacturing so as to increase access to affordable quality medicines for the continent’s 1.3 billion people.
Analysis on the Construction of Sustainable Development Capacity of Pharmaceutical Enterprises from the Aspect of Investment of R&D Expenses Zhulikou431
December 17, 2021
Recently, semi-annual reports of domestic and foreign pharmaceutical companies have been disclosed one after another. From the data released by major companies, we put aside the highly anticipated...
Eleva and 3PBIOVIAN Sign Strategic GMP Manufacturing and Technology Alliance to Boost Capacity for Eleva’s Platform and Pipeline PharmaSources
February 05, 2025
Eleva and 3PBIOVIAN sign a strategic GMP manufacturing and technology alliance to boost capacity for Eleva's platform and pipeline.
High Demand: Vetter Expands Production Capacities and Services Offered at Its Austrian Site PharmaSources
May 10, 2023
Vetter has completed the first year of production in Rankweil successfully and is preparing to further increase production capacities and capabilities on site.
GMP certification for Exothera further extends its viral vector manufacturing capacity PharmaSources.com
March 24, 2022
Exothera S.A., a CDMO specialized in the development and manufacture of viral vectors for vaccines and gene therapies, received Good Manufacturing Practices (GMP) certification from the Federal Agency for Medicines and Health Products...
Catalent Completes Expansion of Advanced Containment Capabilities contractpharma
January 26, 2022
Expansion in large-scale isolator units at Malvern and Dartford, UK facilities to provide advanced containment capabilities for highly...
Sharp Expands Gene Therapy Packaging Capabilities contractpharma
January 26, 2022
Invests in new gene therapy packaging and distribution capacity at EU Heerenveen facility.
Sterling Pharma Expands Early Phase Development Capabilities contractpharma
January 25, 2022
Investing $2.1 million in expansion project to increase chemical and analytical capabilities at its facility in Cary, NC.